无创定量CT评估弥漫性肝病:脂肪变性、铁过载与纤维化
综述阐述无创定量CT在弥漫性肝病中的应用:平扫CT肝衰减值≤40 HU提示至少中度脂肪变性,衰减值>75 HU可触发铁过载评估,多种形态与功能CT特征可提示纤维化,定量CT分期纤维化性能与弹性成像可比,且可回顾性、自动化分析。
要点
- 平扫CT肝衰减值≤40 HU提示至少中度脂肪变性,与MRI质子密度脂肪分数接近。
- 平扫CT肝实质衰减值>75 HU可触发铁过载的适当评估。
- 定量CT分期纤维化性能与弹性成像可比,且可回顾性分析并可由AI全自动完成。
核心结论
- 无创定量CT可用于机会性检出肝脂肪变性、铁过载和纤维化,平扫CT肝衰减值≤40 HU提示至少中度脂肪变性、>75 HU可触发铁过载评估,定量CT分期纤维化性能与弹性成像可比。
研究设计与样本
- 综述,总结无创定量CT评估弥漫性肝病(脂肪变性、铁过载、纤维化)的方法与价值,原文未报告检索范围与纳入文献数。
关键影像表现/征象
- 平扫CT肝衰减值≤40 HU提示至少中度脂肪变性,与MRI质子密度脂肪分数定量接近。
- 增强CT定量肝脂肪精度较低,但通常可做分类评估(如轻度 vs 中度脂肪变性)。
- 平扫CT观察到肝实质衰减值升高(如>75 HU)时可触发铁过载的适当评估。
- 多种形态学和功能CT特征提示 underlying 肝纤维化和肝硬化。
诊断标准与关键数值
- 平扫CT肝衰减值≤40 HU提示至少中度脂肪变性。
- 平扫CT肝实质衰减值>75 HU可触发铁过载评估。
- 定量CT分期纤维化性能与弹性成像可比。
临床应用与阅片要点
- 无论CT检查指征如何,机会性检出脂肪变性、铁过载和纤维化可促成适当的临床认识和处置。
- 定量CT评估可回顾性进行,无需前瞻性技术。
- 许多CT定量指标现已通过人工智能深度学习算法实现全自动分析。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Chronic diffuse liver disease continues to increase in prevalence and represents a global health concern. Noninvasive detection and quantification of hepatic steatosis, iron overload, and fibrosis are critical, especially given the many relative disadvantages and potential risks of invasive liver biopsy. Although MRI techniques have emerged as the preferred reference standard for quantification of liver fat, iron, and fibrosis, CT can play an important role in opportunistic detection of unsuspected disease and is performed at much higher volumes. For hepatic steatosis, noncontrast CT provides a close approximation to MRI-based proton-density fat fraction (PDFF) quantification, with liver attenuation values less than or equal to 40 HU signifying at least moderate steatosis. Liver fat quantification with postcontrast CT is less precise but can generally provide categorical assessment (eg, mild vs moderate steatosis). Noncontrast CT can also trigger appropriate assessment for iron overload when increased parenchymal attenuation values are observed (eg, >75 HU). A variety of morphologic and functional CT features indicate the presence of underlying hepatic fibrosis and cirrhosis. Beyond subjective assessment, quantitative CT methods for staging fibrosis can provide comparable performance to that of elastography. Furthermore, quantitative CT assessment can be performed retrospectively, since prospective techniques are not required. Many of these CT quantitative measures are now fully automated via artificial intelligence (AI) deep learning algorithms. These retrospective and automated advantages have important implications for longitudinal clinical care and research. Ultimately, regardless of the indication for CT, opportunistic detection of steatosis, iron overload, and fibrosis can result in appropriate clinical awareness and management. ©RSNA, 2024 See the invited commentary by Yeh in this issue.
引用
- Pickhardt PJ, Lubner MG. Noninvasive Quantitative CT for Diffuse Liver Diseases: Steatosis, Iron Overload, and Fibrosis. Radiographics. 2025. PMID: 39700040. doi:10.1148/rg.240176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。